We are live on ! Find out more
Rafferty Asset Management

Rafferty Asset Management Portfolio holdings

AUM $24.6B
1-Year Est. Return 47.06%
This Fund
S&P 500
This Quarter Est. Return
+1.12%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$28.3B
AUM Growth
-$930M
Cap. Flow
-$234M
Cap. Flow %
-0.83%
Top 10 Hldgs %
43.26%
Holding
1,183
New
46
Increased
601
Reduced
483
Closed
43

Sector Composition

Rank Sector Weight
1 Technology 41.4%
2 Financials 10.42%
3 Consumer Discretionary 7.12%
4 Healthcare 4.51%
5 Industrials 2.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACAD icon
551
Acadia Pharmaceuticals
ACAD
$4.43B
$2.76M 0.01%
150,234
-135,507
-47% -$2.19M
BEAM icon
552
Beam Therapeutics
BEAM
$2.63B
$2.76M 0.01%
111,100
-75,991
-41% -$1.94M
IBP icon
553
Installed Building Products
IBP
$6.01B
$2.75M 0.01%
15,703
+5,310
+51% +$1.15M
WSFS icon
554
WSFS Financial
WSFS
$4.12B
$2.75M 0.01%
51,681
-3,098
-6% -$169K
MLM icon
555
Martin Marietta Materials
MLM
$31.5B
$2.74M 0.01%
5,311
+193
+4% +$110K
SOC icon
556
Sable Offshore Corp
SOC
$1.01B
$2.74M 0.01%
119,765
+94,684
+378% +$2.07M
AWK icon
557
American Water Works
AWK
$26.7B
$2.72M 0.01%
21,882
-574
-3% -$77.5K
CATY icon
558
Cathay General Bancorp
CATY
$4.22B
$2.72M 0.01%
57,048
-16,576
-23% -$799K
ARDX icon
559
Ardelyx
ARDX
$1.22B
$2.71M 0.01%
534,743
-59,712
-10% -$330K
WST icon
560
West Pharmaceutical
WST
$24B
$2.69M 0.01%
8,218
+860
+12% +$271K
WY icon
561
Weyerhaeuser
WY
$18B
$2.69M 0.01%
95,613
-7,771
-8% -$242K
PPL
562
PPL Corp
PPL
$26.5B
$2.69M 0.01%
82,853
-2,156
-3% -$71K
AEE icon
563
Ameren
AEE
$30.3B
$2.67M 0.01%
29,975
-770
-3% -$69K
FBIN icon
564
Fortune Brands Innovations
FBIN
$5.88B
$2.66M 0.01%
38,913
+7,953
+26% +$637K
CRK icon
565
Comstock Resources
CRK
$3.89B
$2.66M 0.01%
145,861
-15,300
-9% -$212K
XYL icon
566
Xylem
XYL
$27.3B
$2.63M 0.01%
22,693
+2,327
+11% +$294K
APGE icon
567
Apogee Therapeutics
APGE
$10.1B
$2.61M 0.01%
57,673
+3,110
+6% +$159K
ARWR icon
568
Arrowhead Research
ARWR
$11.9B
$2.6M 0.01%
138,377
-42,517
-24% -$876K
EXP icon
569
Eagle Materials
EXP
$6.29B
$2.59M 0.01%
10,506
+2,120
+25% +$612K
NET icon
570
Cloudflare
NET
$99B
$2.59M 0.01%
24,040
+2,053
+9% +$201K
CASH icon
571
Pathward Financial
CASH
$1.86B
$2.59M 0.01%
35,181
-123
-0.3% -$9.37K
PRAX icon
572
Praxis Precision Medicines
PRAX
$8.58B
$2.59M 0.01%
33,629
-1,730
-5% -$125K
SFNC icon
573
Simmons First National
SFNC
$3.41B
$2.59M 0.01%
116,670
+14,105
+14% +$330K
HII icon
574
Huntington Ingalls Industries
HII
$12.9B
$2.58M 0.01%
13,677
+801
+6% +$173K
CDNA icon
575
CareDx
CDNA
$2.26B
$2.56M 0.01%
119,798
+51,559
+76% +$1.25M

Similar funds

Rafferty Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, Rafferty Asset Management held 1,183 positions worth $28.3B, down 3.2% from $29.2B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Rafferty Asset Management's Q4 2024 filing shows 46 new, 601 increased, 483 reduced and 43 closed positions. Its largest new stake was Apollo Global Management: 157,705 shares worth $26M. The largest sale was iShares 20+ Year Treasury Bond ETF, an estimated $495M.

By sector, the portfolio is most concentrated in Technology at 41% of assets, down from 45% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Rafferty Asset Management's largest Q4 2024 buy was Apollo Global Management: 157,705 shares worth $26M.
  • Rafferty Asset Management added most to Tesla in Q4 2024, an estimated $338M increase.
  • Rafferty Asset Management's biggest Q4 2024 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $495M.
  • Rafferty Asset Management fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $9.52M.
  • Rafferty Asset Management's ten largest holdings make up 43% of its $28.3B portfolio in Q4 2024.
  • Rafferty Asset Management opened 46 new positions and closed 43 in Q4 2024.
  • Rafferty Asset Management's portfolio value fell 3.2% quarter-over-quarter to $28.3B.

Based on Rafferty Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.